449541005: Toceranib phosphate (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Transferase inhibitor\Phosphotransferase inhibitor\Protein kinase inhibitor\Protein-tyrosine kinase inhibitor\Toceranib phosphate (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Toceranib phosphate (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Azole\Pyrrole\Toceranib phosphate (substance)

\Organic compound\Organic cyclic compound\Heterocyclic compound\Azole\Pyrrole\Toceranib phosphate (substance)
\Organic compound\Organic nitrogen compound\Azole\Pyrrole\Toceranib phosphate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2011. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

2899150016 Toceranib phosphate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

2901688019 Toceranib phosphate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

846501000172114 phosphate de tocéranib fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Toceranib phosphate (substance)	Is a	Toceranib (substance)	false	Inferred relationship	Some
Toceranib phosphate (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Protein-tyrosine kinase inhibitor (disposition)	true	Inferred relationship	Some
Toceranib phosphate (substance)	Is a	produit chimique catégorisé selon sa fonction	false	Inferred relationship	Some
Toceranib phosphate (substance)	Is a	Protein-tyrosine kinase inhibitor	true	Inferred relationship	Some
Toceranib phosphate (substance)	Is a	Enzyme inhibitor	false	Inferred relationship	Some
Toceranib phosphate (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Toceranib (substance)	true	Inferred relationship	Some
Toceranib phosphate (substance)	Is a	Pyrrole	true	Inferred relationship	Some
Toceranib phosphate (substance)	Is a	A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Toceranib phosphate 10 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Toceranib phosphate (substance)	Inferred relationship	Some
Product containing toceranib phosphate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Toceranib phosphate (substance)	Inferred relationship	Some
Toceranib phosphate 50 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Toceranib phosphate (substance)	Inferred relationship	Some
Toceranib phosphate 15 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Toceranib phosphate (substance)	Inferred relationship	Some
Toceranib phosphate 10 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Toceranib phosphate (substance)	Inferred relationship	Some	1
Toceranib phosphate 10 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Toceranib phosphate (substance)	Inferred relationship	Some	1
Toceranib phosphate 50 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Toceranib phosphate (substance)	Inferred relationship	Some	1
Toceranib phosphate 50 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Toceranib phosphate (substance)	Inferred relationship	Some	1
Toceranib phosphate 15 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Toceranib phosphate (substance)	Inferred relationship	Some	1
Toceranib phosphate 15 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Toceranib phosphate (substance)	Inferred relationship	Some	1
Toceranib phosphate 15 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Toceranib phosphate (substance)	Inferred relationship	Some	1
Toceranib phosphate 10 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Toceranib phosphate (substance)	Inferred relationship	Some	1
Toceranib phosphate 50 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Toceranib phosphate (substance)	Inferred relationship	Some	1

This concept is not in any reference sets